Circulating biomarkers at baseline (■) and after 3 years (

) of supplementation with 500 μg/day phylloquinone (
n = 229) or placebo (
n = 223) in primarily Caucasian community-dwelling men and women 65–80 years old. (Because of skewed distributions, plasma phylloquinone and (dp)ucMgp are presented as median values with error bars representing inter-quartile ranges. Otherwise data are presented as means with error bars representing standard deviations.
p-values reflect the between-group difference for change in the biomarker in response to phylloquinone supplementation
versus placebo).